- Home
- IPHA vs TWIN Comparison
IPHA vs TWIN Comparison
Compare IPHA & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | TWIN |
|---|---|---|
| Founded | 1999 | 1918 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 224.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | TWIN |
|---|---|---|
| Price | $1.71 | $16.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.00 | ★ $12.00 |
| AVG Volume (30 Days) | 25.6K | ★ 26.4K |
| Earning Date | 09-17-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $14,839,695.00 | ★ $347,837,000.00 |
| Revenue This Year | $22.29 | $10.79 |
| Revenue Next Year | $43.90 | $8.43 |
| P/E Ratio | ★ N/A | $910.37 |
| Revenue Growth | N/A | ★ 14.24 |
| 52 Week Low | $1.60 | $6.16 |
| 52 Week High | $2.63 | $17.08 |
Technical Indicators
Market Signals| Indicator | IPHA | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 66.43 |
| Support Level | $1.64 | $15.06 |
| Resistance Level | $1.81 | $15.84 |
| Average True Range (ATR) | 0.08 | 0.57 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 18.75 | 91.97 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.